Pathophysiological explanation of cardiovascular benefits of sodium-glucose cotransporter-2 inhibitors by neurotrophic theory.

M. Hristova
DOI: https://doi.org/10.1016/j.mehy.2017.02.021
IF: 4.7
2017-05-01
Medical Hypotheses
Abstract:
What problem does this paper attempt to address?